• 24/7 ER : +86 10 59850333
  • OASIS : 400-8762-747
当前位置 : Home > Health Knowledge
Pneumococcal 13 Vaccine Now Available at OASIS

13-Valent Pneumococcal Conjugate Vaccine

Pneumococcal 13 (PCV13) has officially come on the market in mainland China. OASIS International Hospital can now provide vaccination services. Appointments can be made through the following number: 010—59850200

Pneumococcal 13

Manufactured by Pfizer

Produced in Ireland

Who can receive this vaccine? 

Infants of 6 weeks to 15 months old

What is the vaccine schedule for infants?

Vaccination is done at 2, 4 and 6 months, with a booster at 12-15 months.

Pneumococcal conjugate vaccine (also called PCV13) protects against 13 types of pneumococcal bacteria. Pneumococcal disease is caused by bacteria that can spread from person to person through close contact. It can cause ear infections, and can also lead to more serious infections of the:

+ Lungs (pneumonia),

Blood (bacteremia), and

Covering of the brain and spinal cord (meningitis).

Important Information to be Aware of

Why is Infant Vaccination Important?

Pneumonia is the single largest infectious cause of death in children worldwide.

    Pneumococcal bacteria can be commonly found within a child’s nose or throat with a carrier rate of 27 – 85%. If inhaled into the lungs, infection can occur. According to statistics, for every 3 children with a lower respiratory tract infection, 1 will carry the pneumococcal bacteria. When your child’s immune system is low, Streptococcus pneumoniae – the most common cause of bacterial pneumonia in children, can strike causing non-invasive pneumococcal diseases such as, Otitis media (middle ear infection), sinusitis and Non-bacteremic pneumonia (LRT infection without the spread of organisms to the blood stream). On the more serious side, invasive pneumococcal disease (IPD) may occur causing Bacteremia (sepsis), Meningitis or Bacteremic pneumonia. Serious complications of IPD could result in long-term problems such as, brain damage and hearing loss or possible death.

    According to the WHO, pneumonia accounts for 16% of all deaths of children under the age of 5 years. Pneumococcal 13 can protect against most serotypes affecting children under the age of 5 with an 87.7% effectiveness.

What is the Difference Between PCV13 and PCV7?

PCV13 supersedes PCV7.

The original seven-valent formulation (PCV7) contains serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F. Whilst this covers only seven strains out of more than ninety strains, these seven strains cause 80% to 90% of cases of severe pneumococcal disease. In 2010, Pfizer introduced Prevnar 13 (PCV13), which contains six additional strains (i.e., 1, 3, 5, 6A, 19A and 7F), this protects against the majority of the remaining pneumococcal infections.

Got Questions?

All questions regarding the Pneumococcal 13 vaccine from “how to”, to “switching over from PCV7” can be referred to OASIS International Hospital’s Pediatric Dept. For specific matters, please call the Pediatrics Dept. at: 010-59850303.

Will PCV13 Protect 100% against Pneumonia?

The answer is no. This vaccination can only reduce the risk of developing pneumonia.

    Out of 90 strains, Pneumococcal 13 can protect against 13 of the most aggressive serotypes causing serious infection in children. In other words, any strain not covered by the PCV13 still has the possibility to infect and cause pneumonia, otitis media etc. Moreover, the causes of pneumonia are also not limited to Streptococcus pneumoniae, it can also be caused by other bacteria, viruses and mycoplasmas.

    In addition to the pneumococcal vaccine, Hib vaccine, influenza vaccine, measles, chicken pox and pertussis vaccine can also be taken to reduce the risk of pneumonia in children.

Can Anyone Receive the Vaccination?

The answer is no.

Currently, the immunization program within mainland China is as follows:

    Pneumococcal 13 vaccination schedule at the earliest can be given to infants of 6 weeks, after which, intervals of 4 to 8 weeks are to be left between shots. The basic vaccination schedule is: 2, 4 and 6 months, with a booster at 12-15 months.

    At present, there is no clinical trial data within China for immunization procedures for children over 6 months. For vaccinations regarding children over the age of 6 months, please consult your doctor.

Vaccination Precautions

Injection Sites

Infants: Injection in the outer thigh

Toddlers: Injection of the upper arm shoulder muscle

    If your child is suffering from acute or severe febrile illness, vaccination should be delayed.

Possible Adverse Reactions & Contraindications

Possible Adverse Reactions:

    Loss of appetite, irritability, drowsiness or restlessness, fever, reddening of the skin at the injection site, hardened bump at injection site, swelling or pain.


    Anyone who experienced an allergic reaction to PCV7 should not be vaccinated with PCV13. 

For information on the OASIS 13-Valent Pneumococcal Conjugate Vaccine Package, call the number seen above.